Leveljump HealthcareTSXV:JUMP EBITDA Margin % is 11.95% as of Sep. 2025. The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Leveljump Healthcare ranks better than 57.84% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Leveljump Healthcare EBITDA Margin % Related Terms
Leveljump Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Leveljump Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:JUMP vs TMO, DHR, IDXX: EBITDA Margin % Comparison
For the Diagnostics & Research subindustry, Leveljump Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leveljump Healthcare EBITDA Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Leveljump Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leveljump Healthcare (TSXV:JUMP) has a EBITDA Margin % of 11.95% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Leveljump Healthcare and its competitors. According to the industry distribution chart, Leveljump Healthcare ranks #86 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 42.2%.
Is Leveljump Healthcare's EBITDA Margin % too high?
Leveljump Healthcare's current EBITDA Margin % is 11.95%. The Medical Diagnostics & Research industry median EBITDA Margin % is 5.20. Leveljump Healthcare's value of 11.95% is 129.8% above this industry median. Based on the distribution chart, Leveljump Healthcare ranks #86 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Leveljump Healthcare's EBITDA Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #86 out of 204 companies for EBITDA Margin %. This puts Leveljump Healthcare in the upper half of its industry. The industry median EBITDA Margin % is 5.20. Leveljump Healthcare's value of 11.95% is 129.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Diagnostics & Research company?
The median EBITDA Margin % among Medical Diagnostics & Research companies is 5.20, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leveljump Healthcare's current EBITDA Margin % of 11.95% is 129.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Leveljump Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA Margin % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leveljump Healthcare's current EBITDA Margin % is 11.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Leveljump Healthcare (TSXV:JUMP) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.07, compared to a current price of C$0.06 — trading 21.4% below its estimated fair value. The current EBITDA Margin % is 11.95% and 129.8% above the Medical Diagnostics & Research industry median of 5.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Leveljump Healthcare (TSXV:JUMP), the current EBITDA Margin % is 11.95% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:JUMP has been successfully added to your 